まとめ
デナーヴァー化した筋肉は,残ったモーターアクソンが発芽し,再発動するようシグナルを与える可能性があります. 肌が消耗した筋肉によって分泌される特定のタンパク質が,この発芽を促進し,それに対する抗体はプロセスをブロックすることができます.
科学分野:
- 神経科学は神経科学である.
- 筋肉生理学 筋肉生理学
- 分子生物学は分子生物学である.
背景:
- 軸索損傷またはモトニューロン喪失は,軸索の芽生えを誘発し,神経化された筋肉繊維の再内化を引き起こします.
- 発芽は,ランヴィエ (節節) と神経筋結節 (末端) の節点で起こります.
- 末端発芽は筋肉の不活性によって誘発され,筋肉由来信号を示唆しています.
研究 の 目的:
- 筋肉の不活性に対する反応として,末端発芽の基礎となる分子メカニズムを調査する.
- 軸索の芽生えと再内核化に関与する潜在的なシグナル伝達分子を特定する.
- この過程における特定の分泌されるタンパク質の役割を調査する.
主な方法:
- ネズミの筋にボツリヌム毒素を用いて末端発芽の誘導.
- ウサギのアンチセラの投与は,神経化したネズミの筋肉によって分泌される56,000分重のタンパク質に対して行われる.
- アミオトロフィック横筋硬化症 (ALS) 患者の血清における56Kタンパク質に対する免疫応答の検出.
主要な成果:
- 56Kタンパク質抑制されたボツリヌム毒素誘発末端発芽に対するウサギのアンチセラ.
- 筋肉に由来する56Kタンパク質は,末端の芽生えを促進することに関与しています.
- この56Kタンパク質に対する免疫反応は,ALS患者で発見されました.
結論:
- デナーバ化された筋肉によって分泌される56Kタンパク質は,末端の芽生えを促進する役割を果たします.
- このタンパク質は,異常な軸索の芽生えを伴う状態を理解し,潜在的に治療するためのターゲットである可能性があります.
- ALS患者のこのタンパク質に対する抗体の存在は,疾患の病理学との関連を示唆しています.
さらに関連する動画
08:41Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
Published on: August 14, 2021
04:44Combined In Vivo Electroporation and Short-Term Reinnervation of the Cranial Levator Auris Longus Skeletal Muscle
Published on: November 1, 2024
関連する概念動画
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Neuromuscular Junction And Blockade
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
01:19The Neuromuscular Junction
The nervous system consists of complex motor neuron circuits, including upper motor neurons originating from the cerebral cortex and lower motor neurons starting in the spinal cord, coordinating both voluntary and involuntary movements. Among these, somatic motor neurons activate skeletal muscles and are classified into alpha, beta, and gamma types. Alpha neurons are vital for voluntary movement coordination, while gamma neurons adjust muscle spindle sensitivity, and the function of beta...
01:26Chemical Synapses
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...